TÜV SÜD are pleased to be a sponsor of the 10th LSX World Congress, the leading partnering, strategy and investment event in Europe.
The event brings together the CEOs and senior decision-makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes.
Martin Witte, Senior Director Strategic Business Development at TÜV SÜD, will be speaking at the event on 29 April at 11:10 in the Medtech stream. Martin is part of the panel discussion on the topic of ‘Innovation = Centralisation?! A Discussion About the future of Innovation in Medtech’.
Come and see Martin, alongside other members of the TÜV SÜD team, who are available at the event for an informal chat or a pre booked meeting.
Martin Witte
Senior Director of Strategic Business Development for Medical Health Services
Martin Witte is Senior Director of Strategic Business Development for Medical Health Services at TÜV SÜD. In his role, he oversees the growth areas Active Medical Implants, Cardiovascular, Orthopaedic, Software, AI and IVDs. Martin previously served as a Lead Auditor and Product Specialist, showcasing expertise in evaluating high-risk devices. His background includes a role as Regulatory Affairs Manager at BIOTRONIK, focusing on heart rhythm management devices and MRI safety of active implantable devices.
Site Selector
Global
Americas
Asia
Europe
Middle East and Africa
